HealthSouth (NYSE: HLS ) reported earnings on April 26. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), HealthSouth beat expectations on revenues and missed estimates on earnings per share.
Compared with the prior-year quarter, revenue was unchanged and GAAP earnings per share dropped significantly.
Gross margins shrank, operating margins improved, net margins dropped.
HealthSouth reported revenue of $538.6 million. The 12 analysts polled by S&P Capital IQ anticipated revenue of $525.8 million on the same basis. GAAP reported sales were 5.2% higher than the prior-year quarter's $506.0 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.37. The 13 earnings estimates compiled by S&P Capital IQ anticipated $0.39 per share. GAAP EPS of $0.39 for Q1 were 51% lower than the prior-year quarter's $0.79 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 46.0%, 70 basis points worse than the prior-year quarter. Operating margin was 20.0%, 50 basis points better than the prior-year quarter. Net margin was 8.3%, 750 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $530.1 million. On the bottom line, the average EPS estimate is $0.37.
Next year's average estimate for revenue is $2.12 billion. The average EPS estimate is $1.47.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on HealthSouth is outperform, with an average price target of $24.85.
Over the decades, small-cap stocks like HealthSouth have provided market-beating returns, provided they're value-priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: Two Small Caps the Government Won't Let Go Broke." Get instant access to this free report.
- Add HealthSouth to My Watchlist.